These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 17570802

  • 1. Should menopausal women at increased risk for breast cancer use tamoxifen, raloxifene, or hormone therapy?: a framework for personalized risk assessment and counseling.
    Matloff ET, Shannon KM, Moyer A, Col NF.
    J Cancer Educ; 2007; 22(1):10-4. PubMed ID: 17570802
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
    Chlebowski RT, Collyar DE, Somerfield MR, Pfister DG.
    J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR).
    Runowicz CD, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Ford LG, Vogel VG, Wolmark N.
    Am J Obstet Gynecol; 2011 Dec; 205(6):535.e1-5. PubMed ID: 21872200
    [Abstract] [Full Text] [Related]

  • 7. From adjuvant therapy to breast cancer prevention: BCPT and STAR.
    Dunn BK, Ford LG.
    Breast J; 2001 Dec; 7(3):144-57. PubMed ID: 11469927
    [Abstract] [Full Text] [Related]

  • 8. Risk versus Benefit of Chemoprevention among Raloxifene and Tamoxifen Users with a Family History of Breast Cancer.
    Anderson C, Nichols HB, House M, Sandler DP.
    Cancer Prev Res (Phila); 2019 Nov; 12(11):801-808. PubMed ID: 31431499
    [Abstract] [Full Text] [Related]

  • 9. Exemestane for primary prevention of breast cancer in postmenopausal women.
    Zhang Y, Simondsen K, Kolesar JM.
    Am J Health Syst Pharm; 2012 Aug 15; 69(16):1384-8. PubMed ID: 22855103
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tamoxifen versus raloxifene in the prevention of breast cancer.
    Wickerham DL.
    Eur J Cancer; 2002 Nov 15; 38 Suppl 6():S20-1. PubMed ID: 12409060
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.
    Freedman AN, Yu B, Gail MH, Costantino JP, Graubard BI, Vogel VG, Anderson GL, McCaskill-Stevens W.
    J Clin Oncol; 2011 Jun 10; 29(17):2327-33. PubMed ID: 21537036
    [Abstract] [Full Text] [Related]

  • 15. Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.
    Nelson HD, Smith ME, Griffin JC, Fu R.
    Ann Intern Med; 2013 Apr 16; 158(8):604-14. PubMed ID: 23588749
    [Abstract] [Full Text] [Related]

  • 16. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
    Bober SL, Hoke LA, Duda RB, Regan MM, Tung NM.
    J Clin Oncol; 2004 Dec 15; 22(24):4951-7. PubMed ID: 15598980
    [Abstract] [Full Text] [Related]

  • 17. Chemoprevention of breast cancer: implications for postmenopausal women.
    Fabian CJ, Kimler BF.
    Drugs Aging; 2002 Dec 15; 19(1):43-78. PubMed ID: 11929326
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Status of antiestrogen breast cancer prevention trials.
    Powles TJ.
    Oncology (Williston Park); 1998 Mar 15; 12(3 Suppl 5):28-31. PubMed ID: 9556788
    [Abstract] [Full Text] [Related]

  • 20. Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials.
    Vogel VG, Costantino JP, Wickerham DL, McCaskill-Stevens W, Clarfeld RB, Grant MD, Wolmark N.
    J Natl Cancer Inst Monogr; 2010 Mar 15; 2010(41):181-6. PubMed ID: 20956826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.